67 / 76
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 2, March/April 2017
AFRICA
133
Gao P,
et al.
C-reactive protein, fibrinogen, and cardiovascular disease
prediction.
N Engl J Med
2012;
367
(14): 1310–1320.
67. Kaptoge S, Seshasai SRK, Gao P, Freitag DF, Butterworth AS,
Borglykke A,
et al.
Inflammatory cytokines and risk of coronary heart
disease: new prospective study and updated meta-analysis.
Eur Heart J
2014;
35
(9): 578–589.
68. Daniels LB, Clopton P, Laughlin GA, Maisel AS, Barrett-Connor E.
Growth-differentiation factor-15 is a robust, independent predictor of
11-year mortality risk in community-dwelling older adults: the Rancho
Bernardo study.
Circulation
2011;
123
(19): 2101–2110.
69. Mogelvang R, Pedersen SH, Flyvbjerg A, Bjerre M, Iversen AZ,
Galatius S,
et al
. Comparison of osteoprotegerin to traditional athero-
sclerotic risk factors and high-sensitivity C-reactive protein for diagnosis
of atherosclerosis.
Am J Cardiol
2012;
109
(4): 515–520.
70. Rana JS, Arsenault BJ, Després J-P, Côté M, Talmud PJ, Ninio E,
et al
.
Inflammatory biomarkers, physical activity, waist circumference, and
risk of future coronary heart disease in healthy men and women.
Eur
Heart J
2009;
32
(3): 336–344.
71. Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R,
Saleheen D,
et al.
B-type natriuretic peptides and cardiovascular
risk systematic review and meta-analysis of 40 prospective studies.
Circulation
2009;
120
(22): 2177–2187.
72. Humphrey LL, Fu R, Rogers K, FreemanM, HelfandM. Homocysteine
level and coronary heart disease incidence: a systematic review and
meta-analysis.
Mayo Clin Proc
2008;
83
(11): 1203–1212.
73. Homocysteine Studies Collaboration. Homocysteine and risk of
ischemic heart disease and stroke: a meta-analysis.
J Am Med Assoc
2002;
288
(16): 2015–2022.
74. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt
P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and
urinary albumin levels as predictors of mortality and cardiovascular
events in older adults.
J Am Med A
ssoc 2005;
293
(13): 1609–1616.
75. Pai JK, Cahill LE, Hu FB, Rexrode KM, Manson JE, Rimm EB.
Hemoglobin A
1c
is associated with increased risk of incident coronary
heart disease among apparently healthy, nondiabetic men and women.
J
Am Heart Assoc
2013;
2
(2): e000077.
76. Schneider HJ, Wallaschofski H, Volzke H, Markus MR, Doerr M, Felix
SB,
et al.
Incremental effects of endocrine and metabolic biomarkers
and abdominal obesity on cardiovascular mortality prediction.
PloS
One
2012;
7
(3): e33084.
77. Kanhai D, Kranendonk M, Uiterwaal C, Graaf Y, Kappelle L, Visseren
F. Adiponectin and incident coronary heart disease and stroke. A
systematic review and meta‐analysis of prospective studies.
Obes Rev
2013;
14
(7): 555–567.
78. Smith GD, Ben-Shlomo Y, Beswick A, Yarnell J, Lightman S, Elwood P.
Cortisol, testosterone, and coronary heart disease: prospective evidence
from the Caerphilly study.
Circulation
2005;
112
(3): 332–340.
79. Hamer M, Endrighi R, Venuraju SM, Lahiri A, Steptoe A. Cortisol
responses to mental stress and the progression of coronary artery calci-
fication in healthy men and women.
PloS One
. 2012;
7
(2): e31356.
80. Noble EE, Billington CJ, Kotz CM, Wang C. The lighter side of BDNF.
Am J Physiol Regul Integr Comp Physiol
2011;
300
(5): R1053.
81. Karatsoreos IN, McEwen BS. Psychobiological allostasis: resistance,
resilience and vulnerability.
Trends Cogn Sci
2011;
15
(12): 576–584.
82. Calabrese F, Molteni R, Racagni G, Riva MA. Neuronal plasticity: a
link between stress and mood disorders.
Psychoneuroendocrinology
2009;
34
: S208
-
S216.
83. Gast KB, Tjeerdema N, Stijnen T, Smit JW, Dekkers OM. Insulin
resistance and risk of incident cardiovascular events in adults without
diabetes: meta-analysis.
PloS One
2012;
7
(12): e52036.